DE60210970D1 - Mutante formen von etxb und ctxb und ihre verwendung als träger - Google Patents

Mutante formen von etxb und ctxb und ihre verwendung als träger

Info

Publication number
DE60210970D1
DE60210970D1 DE60210970T DE60210970T DE60210970D1 DE 60210970 D1 DE60210970 D1 DE 60210970D1 DE 60210970 T DE60210970 T DE 60210970T DE 60210970 T DE60210970 T DE 60210970T DE 60210970 D1 DE60210970 D1 DE 60210970D1
Authority
DE
Germany
Prior art keywords
etxb
ctxb
carrier
mutant
mutant forms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60210970T
Other languages
English (en)
Other versions
DE60210970T2 (de
Inventor
Raymond Hirst
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hunter Immunology Pty Ltd
Original Assignee
TIMOTHY R HIRST CONSULTING Pty Ltd
TIMOTHY R HIRST CONSULTING Pty
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by TIMOTHY R HIRST CONSULTING Pty Ltd, TIMOTHY R HIRST CONSULTING Pty filed Critical TIMOTHY R HIRST CONSULTING Pty Ltd
Publication of DE60210970D1 publication Critical patent/DE60210970D1/de
Application granted granted Critical
Publication of DE60210970T2 publication Critical patent/DE60210970T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/28—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Vibrionaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/385—Haptens or antigens, bound to carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/6415—Toxins or lectins, e.g. clostridial toxins or Pseudomonas exotoxins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245—Escherichia (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
DE60210970T 2001-06-22 2002-06-20 Mutante formen von etxb und ctxb und ihre verwendung als träger Expired - Lifetime DE60210970T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0115382 2001-06-22
GBGB0115382.4A GB0115382D0 (en) 2001-06-22 2001-06-22 Mutant
PCT/GB2002/002829 WO2003000899A1 (en) 2001-06-22 2002-06-20 MUTANT FORMS OF EtxB AND CtxB AND THEIR USE AS CARRIERS

Publications (2)

Publication Number Publication Date
DE60210970D1 true DE60210970D1 (de) 2006-06-01
DE60210970T2 DE60210970T2 (de) 2007-01-04

Family

ID=9917219

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60210970T Expired - Lifetime DE60210970T2 (de) 2001-06-22 2002-06-20 Mutante formen von etxb und ctxb und ihre verwendung als träger

Country Status (7)

Country Link
US (2) US7422752B2 (de)
EP (1) EP1402039B1 (de)
AT (1) ATE324446T1 (de)
DE (1) DE60210970T2 (de)
ES (1) ES2260445T3 (de)
GB (1) GB0115382D0 (de)
WO (1) WO2003000899A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2621349A1 (en) * 2004-10-06 2006-04-20 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Acting For The Louisiana State University Health Scie Channel current cheminformatics and bioengineering methods for immunological screening, single-molecule analysis, and single-molecular-interaction analysis
US9120111B2 (en) 2012-02-24 2015-09-01 Rain Bird Corporation Arc adjustable rotary sprinkler having full-circle operation and automatic matched precipitation
US9156043B2 (en) 2012-07-13 2015-10-13 Rain Bird Corporation Arc adjustable rotary sprinkler with automatic matched precipitation
CN111978409B (zh) 2013-03-15 2024-01-26 因斯瑞拜奥有限公司 自组装合成蛋白
WO2018111018A2 (ko) * 2016-12-16 2018-06-21 한양대학교 에리카산학협력단 플라스미드 기반의 ｃｔｘ 파지 복제시스템 및 ｃｔｘ 파지에 감염되고 콜레라 독소를 생산할 수 있는 비브리오 콜레라 균주
US11136358B2 (en) 2016-12-16 2021-10-05 Industry-University Cooperation Foundation Hanyang University Erica Campus Plasmid-based CTX phage replication system and vibrio cholerae strain that can be infected by CTX phage and can be used for cholera toxin production
CN113388008B (zh) * 2021-06-25 2023-04-28 太原师范学院 一种细胞内质网靶向的自释放型蛋白运输载体lca2及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9513733D0 (en) * 1995-07-05 1995-09-06 Univ Bristol Therapeutic agents
AU3939499A (en) * 1998-05-08 1999-11-29 University Of Bristol, The Vaccine
GB9819484D0 (en) * 1998-09-07 1998-10-28 Univ Bristol Therapeutic agents
CA2385172A1 (en) * 1999-10-08 2001-04-19 Active Biotech Ab Ab5 toxin b subunit mutants with altered chemical conjugation characteristics

Also Published As

Publication number Publication date
ES2260445T3 (es) 2006-11-01
US20060002905A1 (en) 2006-01-05
EP1402039B1 (de) 2006-04-26
US8425917B2 (en) 2013-04-23
EP1402039A1 (de) 2004-03-31
GB0115382D0 (en) 2001-08-15
WO2003000899A1 (en) 2003-01-03
US20080305125A1 (en) 2008-12-11
US7422752B2 (en) 2008-09-09
DE60210970T2 (de) 2007-01-04
ATE324446T1 (de) 2006-05-15

Similar Documents

Publication Publication Date Title
TR200200068T2 (tr) Nematisital triflüorobütenler
WO2003000038A3 (en) Compositions and methods for modulating plant development
ATE490311T1 (de) Mutanten der alpha-amylase
ID23374A (id) Halogenopirimidin
TW200612945A (en) Aerosol suspension formulations containing TG 227 ea as propellant
SG158141A1 (en) Pancreatic polypeptide family motifs, polypeptides and methods comprising the same
DE50213462D1 (de) Beschichtung von stents zur verhinderung von restenose
YU9404A (sh) Multimerna, usmerena kontrastna sredstva na bazi peptida
DE60137307D1 (de) Substituierte sapogenine und ihre verwendung
DE69904249D1 (de) 2,2-Dimethylcyclopropansäureester und ihre Verwendung als Pestizide
DE50208918D1 (de) 6-aminomorphinanderivate, herstellungsverfahren dafür und deren verwendung
ATE362469T1 (de) 2,7-disubstituierteindole und ihre verwendung als 5-ht6 modulatoren
DE60210970D1 (de) Mutante formen von etxb und ctxb und ihre verwendung als träger
MY136297A (en) Piperazine derivatives having sst1 antagonistic activity
ATE288922T1 (de) Bestimmte heteroaryl substituierte thiol inhibitoren von endothelin wechselnden enzymen
ATE253059T1 (de) Substituierte 3-phenyl-5-alkoxi-1,3,4-oxdiazol-2- one und ihre verwendung als lipase-hemmer
SG146640A1 (en) Isolated photoprotein mtclytin, and use thereof
DE50313185D1 (de) 2-pyrrolidin-2-yl-ä1,3,4ü -oxadiazol-derivate und ihre verwendung als antidepressiva
DE60319989D1 (de) Diazabicylononan - und decanderivate und ihre verwendung als opioid-rezeptorligande
WO2003091447A3 (en) D1-1 nucleic acids, polypeptides and related methods
ATE366245T1 (de) Benzothia(dia)zinderivate und ihre verwendung als ampa-modulatoren
AU6832498A (en) Substituted benzyl oximino compounds
ID27656A (id) Turunan azabisikloheptana n-tersubstitusi, pembuatan dan penggunaannya
DE59808166D1 (de) Verwendung von 2-methyl-thiazolidin-2,4-dicarbonsäure als mukolytikum
BR9808210A (pt) Befeniloxazolinas dissubstituìdas

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: HUNTER IMMUNOLOGY LTD., FRENCHS FOREST, NEW SO, AU